Search

Search Constraints

You searched for: Author/Creator Kurosaki, Masayuki

Search Results

71. The dynamics of quantitative SARS‐CoV‐2 antispike IgG response to BNT162b2 vaccination. Issue 12 (5th August 2021)

72. Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib. Issue 1 (6th September 2019)

75. Up‐to‐seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child–Pugh grade deterioration after initial conventional transarterial chemoembolization. Issue 6 (9th February 2018)

76. Use of simeprevir following pre‐emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12‐week pilot study. (22nd October 2014)

77. Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma. Issue 1 (4th October 2022)

78. Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. Issue 8 (13th July 2020)

79. Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog. Issue 9 (11th February 2020)

80. Validation of magnetic resonance elastography plus fibrosis‐4 for significant fibrosis in nonalcoholic fatty liver disease. Issue 9 (3rd June 2022)